Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002003 · ClinicalTrials.gov registry record · Phase 2
Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas
A Phase 2 study, sponsored by Lederle Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002003: Completed Phase 2 study, sponsored by Lederle Laboratories.
NCT00002003 is a Phase 2 study that has completed, run by Lederle Laboratories. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002003, a Phase 2 study, has completed, sponsored by Lederle Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
To determine the efficacy and toxicity of the combination of mitoxantrone hydrochloride ( Novantrone ) and etoposide in the treatment of patients with HIV associated lymphomas.
Interventions
- DRUG Etoposide
- DRUG Mitoxantrone hydrochloride
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 2 |
What the finished NCT00002003 record still lists
NCT00002003 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Etoposide is the first listed.
NCT00002003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002003 about?
NCT00002003 is a clinical study titled "Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas". To determine the efficacy and toxicity of the combination of mitoxantrone hydrochloride ( Novantrone ) and etoposide in the treatment of patients with HIV associated lymphomas.
What is the current status of trial NCT00002003?
This trial is currently completed. It is a Phase 2 study.
What interventions are being tested in trial NCT00002003?
The interventions under investigation include: Etoposide (DRUG), Mitoxantrone hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00002003?
This trial is sponsored by Lederle Laboratories, which has 6 total clinical trials registered on ClinicalTrials.gov.